Table 1.
Information on all mice used in the study
| Mouse # | Mouse strain | Sex | Age at injection | rAAV | MRIgFUS |
|---|---|---|---|---|---|
| M1-nTg | nTgCRND8 | male | 13 weeks | 1E11 GC rAAV9 | yes |
| F2-Tg | TgCRND8 | female | 12 weeks | 1E11 GC rAAV9 | yes |
| M3-Tg | TgCRND8 | male | 13 weeks | 1E11 GC rAAV9 | yes |
| M4-Tg | TgCRND8 | male | 13 weeks | 1E11 GC rAAV9 | yes |
| F5-nTg | nTgCRND8 | female | 12 weeks | 1E11 GC rAAV9 | yes |
| M6-nTg | nTgCRND8 | male | 12 weeks | 1E10 GC PHP.B | yes |
| M7-Tg | TgCRND8 | male | 12 weeks | 1E10 GC PHP.B | yes |
| M8-Tg | TgCRND8 | male | 11 weeks | 1E10 GC PHP.B | yes |
| F9-nTg | nTgCRND8 | female | 12 weeks | 1E10 GC PHP.B | yes |
| M10-nTg | nTgCRND8 | male | 12 weeks | 1E10 GC PHP.B | yes |
| M11-nTg | nTgCRND8 | male | 11 weeks | 1E11 GC PHP.B | yes |
| F12-Tg | TgCRND8 | female | 12 weeks | 1E11 GC PHP.B | yes |
| M13-Tg | TgCRND8 | male | 11 weeks | 1E11 GC PHP.B | yes |
| F14-nTg | nTgCRND8 | female | 11 weeks | 1E11 GC PHP.B | yes |
| M15-nTg | nTgCRND8 | male | 11 weeks | 1E11 GC PHP.B | yes |
| 1−3 | BALB/c | male | 12 weeks | 1E11 GC rAAV9 | yes |
| 4−6 | BALB/c | female | 13 weeks | 1E11 GC rAAV9 | yes |
| 7−9 | BALB/c | male | 12 weeks | 1E11 GC PHP.B | yes |
| 10−12 | BALB/c | female | 13 weeks | 1E11 GC PHP.B | yes |